Nicholas Investment Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,786
Closed -$1.09M 220
2026
Q1
$1.09M Sell
11,786
-86,430
-88% -$8.68M 0.08% 178
2025
Q4
$10M Buy
98,216
+14,310
+17% +$1.28M 0.73% 48
2025
Q3
$5.24M Sell
83,906
-119,124
-59% -$6.48M 0.4% 90
2025
Q2
$10.6M Sell
203,030
-31,607
-13% -$1.41M 0.94% 22
2025
Q1
$10M Buy
+234,637
New +$10.1M 1.03% 22
2022
Q2
Sell
-170,198
Closed -$11.3M 188
2022
Q1
$11.3M Buy
170,198
+57,985
+52% +$3.97M 0.8% 43
2021
Q4
$11.2M Buy
112,213
+17,850
+19% +$1.85M 0.71% 52
2021
Q3
$11.8M Sell
94,363
-32,860
-26% -$3.9M 0.86% 44
2021
Q2
$15.8M Sell
127,223
-27,284
-18% -$3.67M 0.99% 35
2021
Q1
$23.6M Buy
154,507
+2,459
+2% +$372K 1.64% 7
2020
Q4
$19.6M Buy
152,048
+13,948
+10% +$1.6M 1.51% 20
2020
Q3
$15.4M Buy
138,100
+122,113
+764% +$11.2M 1.67% 18
2020
Q2
$1.3M Sell
15,987
-26,609
-62% -$2.14M 0.26% 127
2020
Q1
$2.96M Buy
42,596
+358
+0.8% +$27.5K 0.58% 72
2019
Q4
$3.3M Sell
42,238
-51,434
-55% -$3.71M 0.34% 100
2019
Q3
$5.98M Sell
93,672
-244
-0.3% -$21.5K 0.5% 67
2019
Q2
$8.11M Buy
+93,916
New +$7.17M 0.74% 37

Other funds holding GH

Nicholas Investment Partners's GH Position: Q2 2026 in Review

Nicholas Investment Partners sold out of Guardant Health (GH) in Q2 2026, closing a stake of 11,786 shares — an estimated $1.09M sold.

Nicholas Investment Partners first reported a position in GH in Q2 2019 and held it in 17 quarters. The position peaked at $23.6M in Q1 2021. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Nicholas Investment Partners reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Nicholas Investment Partners sold 11,786 Guardant Health shares in Q2 2026, an estimated $1.09M.
  • Nicholas Investment Partners first reported a position in Guardant Health in Q2 2019 and held it in 17 quarters.
  • Nicholas Investment Partners's Guardant Health position peaked at $23.6M in Q1 2021.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.